Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Boileau

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|October 22, 2022
[New European approval: Relatlimab/nivolumab in first -line treatment of advanced metastatic melanoma with less than 1% tumor expression of PD-L1]Marie Boileau, Lise Boussemart
European Journal of Cancer (Oxford, England : 1990)|February 5, 2023
Tenofovir-induced osteoporosis fracture in a patient using PrEP: A pitfall for the oncologistMarie Boileau, Emilie Routier, Arnaud Pouvelle, et al.
Melanoma Research|February 8, 2024
Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practiceGuillaume Delzenne, Marie Boileau, Philippe Jamme, et al.
Melanoma Research|May 2, 2025
Resolution of diffuse cuticular melanosis under immunotherapy in a patient with metastatic melanomaMarie Chaveron, Elise Toulemonde, Eve Desmedt, et al.
Bulletin Du Cancer|May 7, 2025
[Antigen vaccines in melanoma: Towards a new therapeutic paradigm]Clément Svabek, Sophie Maiezza, Eve Desmedt, et al.
The Oncologist|November 17, 2025
Real-life follow-up after discontinuation of anti-PD1 therapy for complete-response cutaneous squamous cell carcinoma in patients over 75 years of ageJulie Lardenois, Eve Desmedt, Sophie Maiezza, et al.
Biology|December 19, 2020
Lipid Metabolism and Resistance to Anticancer TreatmentNicolas Germain, Mélanie Dhayer, Marie Boileau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Neoadjuvant Sonic Hedgehog Inhibitors Combined With Radiotherapy Is a Promising Strategy for Locally Advanced Basal Cell CarcinomaMarie Boileau, Alexandre Taillez, Pauline Lemoine, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell CarcinomaMarie Boileau, Manon Dubois, Henry Abi Rached, et al.
Skin Health and Disease|August 6, 2024
Pseudoxanthoma elasticum, a difficult diagnostic in patient with dark skinCarla Fassanaro, Morgane Stichelbout, Marc Lambert, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|October 22, 2022
[New European approval: Relatlimab/nivolumab in first -line treatment of advanced metastatic melanoma with less than 1% tumor expression of PD-L1]Marie Boileau, Lise Boussemart
European Journal of Cancer (Oxford, England : 1990)|February 5, 2023
Tenofovir-induced osteoporosis fracture in a patient using PrEP: A pitfall for the oncologistMarie Boileau, Emilie Routier, Arnaud Pouvelle, et al.
Melanoma Research|February 8, 2024
Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practiceGuillaume Delzenne, Marie Boileau, Philippe Jamme, et al.
Melanoma Research|May 2, 2025
Resolution of diffuse cuticular melanosis under immunotherapy in a patient with metastatic melanomaMarie Chaveron, Elise Toulemonde, Eve Desmedt, et al.
Bulletin Du Cancer|May 7, 2025
[Antigen vaccines in melanoma: Towards a new therapeutic paradigm]Clément Svabek, Sophie Maiezza, Eve Desmedt, et al.
The Oncologist|November 17, 2025
Real-life follow-up after discontinuation of anti-PD1 therapy for complete-response cutaneous squamous cell carcinoma in patients over 75 years of ageJulie Lardenois, Eve Desmedt, Sophie Maiezza, et al.
Biology|December 19, 2020
Lipid Metabolism and Resistance to Anticancer TreatmentNicolas Germain, Mélanie Dhayer, Marie Boileau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Neoadjuvant Sonic Hedgehog Inhibitors Combined With Radiotherapy Is a Promising Strategy for Locally Advanced Basal Cell CarcinomaMarie Boileau, Alexandre Taillez, Pauline Lemoine, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell CarcinomaMarie Boileau, Manon Dubois, Henry Abi Rached, et al.
Skin Health and Disease|August 6, 2024
Pseudoxanthoma elasticum, a difficult diagnostic in patient with dark skinCarla Fassanaro, Morgane Stichelbout, Marc Lambert, et al.
Pageof 3